N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review
Download in electronic PDF format for $75
Abstract: Contrast medium–induced nephropathy (CIN) is a preventable complication of administration of radiocontrast agents used in procedures such as cardiac catheterization. Hydration with 0.45% sodium chloride solution is the current standard for preventing CIN. Oral N-acetylcysteine, along with hydration with 0.45% sodium chloride solution, is gaining acceptance nationwide as a promising preventive protocol for CIN. N-acetylcysteine is well tolerated by patients: no major side effects have been reported. Compounding pharmacists can play an important role in preventing CIN by compounding N-acetylcysteine into a palatable capsule form that will improve patient compliance and by counseling patients on the importance of keeping hydrated prior to contrast medium procedures.
Related Keywords:
N-acetylcysteine, radiographic procedures, cardiac catheterization, contrast medium, contrast-induced nephropathy, hydration, renal failure, kidney failure
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review
McElhiney Linda F
|
Mar/Apr 2005
Pg. 99-103
|
Compatibility of Melphalan in Iodinated Contrast Media
Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin
|
Jan/Feb 2020
Pg. 83-85
|
Acetylcysteine 200-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 417
|
Acetylcysteine 200-mg Packets
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 418
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 396-400
|
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Zur Eyal
|
Nov/Dec 2018
Pg. 446-454
|
Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 408
|
Standard Operating Procedure: Procedures in the Event of Nonconformance of Bulk Chemicals or Compounded Preparations
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 381
|
Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 156
|
Standard Operating Procedure: Incubator Temperature Monitoring
Allen Loyd V Jr
|
May/Jun 2003
Pg. 228-229
|
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert, Brensel Scott, Ng Amy
|
Nov/Dec 2013
Pg. 465-475
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Mar/Apr 2024
Pg. 111-116
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
Standard Operating Procedure: Washing Glassware and Equipment Used in Compounding Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 470
|
Standard Operating Procedure: Disposal of Chemicals
Allen Loyd V Jr
|
May/Jun 2004
Pg. 210
|
Acetylcysteine 10% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 1997
Pg. 320
|
Standard Operating Procedure: Certificates of Analysis of Materials Used for Pharmaceutical Compounding
|
Mar/Apr 2001
Pg. 147
|
Acetylcysteine 15% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 1998
Pg. 222
|
General Aseptic Procedures Used at a Laminar Airflow Workbench
Allen Loyd V Jr
|
May/Jun 1998
Pg. 242
|
| Return to Top |
